Results 21 to 30 of about 113,275 (214)

Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide [PDF]

open access: yes, 2000
Remission, relapse, and re-remission of proliferative lupus nephritis treated with cyclophosphamide.BackgroundLong-term intravenous cyclophosphamide (IVC) in combination with corticosteroids is standard therapy for proliferative lupus nephritis, but it ...
Kyriaki A. Boki   +20 more
core   +1 more source

Molecular mechanisms governing the progression of nephritis in lupus prone mice and human lupus patients

open access: yesFrontiers in Immunology, 2023
IntroductionPathologic inflammation is a major driver of kidney damage in lupus nephritis (LN), but the immune mechanisms of disease progression and risk factors for end organ damage are poorly understood.MethodsTo characterize molecular profiles through
Andrea R. Daamen   +10 more
doaj   +1 more source

Tubulointerstitial Nephritis and Uveitis Syndrome: Are Drugs Offenders or Bystanders? [PDF]

open access: yes, 2016
A 16-year-old female patient was admitted to our hospital due to progressive renal dysfunction with an increased serum creatinine (sCr) level of 1.7 mg/dL.
Daisuke Nagata   +9 more
core   +1 more source

The Association of Angiotension Converting Enzyme Gene Polimorphism with Prognosis of Henoch-Schönlein Purpura with Renal Involvement in the Children

open access: yesNamık Kemal Tıp Dergisi, 2020
Aim:Henoch-Schönlein purpura (HSP) is a vasculitis rarely progresses to renal failure. The mechanism of renal failure in HSP has been associated with increased angiotensin converting enzyme (ACE) activity and increased local angiotension-II concentration
Sevliya ÖCAL DEMİR, Müferet ERGÜVEN
doaj   +1 more source

Loss of interleukin-1 beta is not protective in the lupus-prone NZM2328 mouse model

open access: yesFrontiers in Immunology, 2023
Aberrant activation of the innate immune system is a known driver of lupus pathogenesis. Inhibition of the inflammasome and its downstream signaling components in murine models of lupus has been shown to reduce the severity of disease. Interleukin-1 beta
Shannon N. Loftus   +11 more
doaj   +1 more source

ARMY NEPHRITIS. [PDF]

open access: yesThe Lancet, 1918
n ...
openaire   +1 more source

Diagnostic and Management Strategies of Tubulointerstitial Nephritis and Uveitis Syndrome (TINU): Current Perspectives [PDF]

open access: yes, 2023
Julia Sanchez-Quiros,1,* Lena Giralt,2,* Alejandro Fonollosa,3,4 Ignacio Robles,5 Ester Carreño1,6 1Department of Ophthalmology, Rey Juan Carlos University Hospital, Madrid, Spain; 2Department of Ophthalmology, Hospital Clinic of Barcelona (ICOF),
Carreño E   +4 more
core  

Immunoglobulin a vasculitis after a not so innocuous wasp bite

open access: yesIndian Pediatrics Case Reports, 2022
Background: Immunoglobulin A vasculitis (IgAV), previously known as Henoch–Schonlein purpura (HSP), is the most common vasculitis in children. Previous studies have identified various triggers of IgAV, with infections being the most common.
Aditi Sharma   +2 more
doaj   +1 more source

Serum cytokine profile in patients with active lupus nephritis [PDF]

open access: yes, 2012
Determination of disease activity of lupus nephritis remains challenging. Since cytokines play a role as inflammatory mediators extending renal injury, measuring serum cytokine levels might help in the clinical assessment of patients with lupus nephritis.
Eisenberger, U.   +11 more
core   +1 more source

Lupus nephritis

open access: yesKidney International, 1997
Contains fulltext : 24337___.PDF (Publisher’s version ) (Open Access)
openaire   +3 more sources

Home - About - Disclaimer - Privacy